Journal of Public Health, Vol. 41, No. 2 (June 2019), pp. 329-337 (9 pages) Background We performed the first epidemiologic investigation to examine association of demographics and clinical ...

Akebia Therapeutics (($AKBA)) announced an update on their ongoing clinical study. Akebia Therapeutics has initiated a study titled A Multicenter, ...

Pediatric patients with anemia and chronic kidney disease can alternate between maintenance erythropoiesis-stimulating agents and subcutaneous continuous erythropoietin receptor activators every 4 ...

Please provide your email address to receive an email when new articles are posted on . Rates of screening for stroke risk with transcranial Doppler have increased since 2014 but remain low. Treatment ...

Anemia in babies may manifest as pale skin, irritability, and a fast heart rate. Sometimes, mild to moderate anemia may not produce symptoms, but severe anemia can have very serious consequences. A ...

In 2019, less than half of children aged 2 to 16 years with sickle cell anemia received the recommended screening for stroke, a common complication of the disease. Few children with sickle cell anemia ...

Researchers have revealed that hydroxyurea significantly reduces infections in children with sickle cell anemia. Their findings enhance strong evidence of hydroxyurea's effectiveness and could ...

Researchers at UCL and University of Ghana have successfully predicted whether children have anemia using only a set of smartphone images. The study, published in PLOS ONE, brought together ...

Thalassemia is a common genetic condition affecting red blood cells. Children with severe forms of thalassemia often develop symptoms early in life, but effective treatment can manage the condition.

Anemia, a condition marked by low levels of hemoglobin in the blood, affects nearly 2 billion people worldwide. Among them, school-age children in low- and middle-income countries are particularly ...

Akebia Therapeutics (($AKBA)) announced an update on their ongoing clinical study. Akebia Therapeutics recently updated its clinical study titled ...